From Rapid Synaptic Events to Lasting Antidepressant States: Convergent and Divergent Mechanisms of Ketamine and Psychedelics
Authors:
- Jihye KimJKJihye Kim
- Manoela V. FogacaMFManoela V. Fogaca
- Hermany MungubaHMHermany Munguba
- Marco PignatelliMPMarco Pignatelli
- Jimcy PlatholiJPJimcy Platholi
- Samuel C. WoodburnSWSamuel C. Woodburn
- Zhenzhong Zack MaZMZhenzhong Zack Ma
- 11 November 2026
- journal article
- Published by Society for Neuroscience in The Journal of Neuroscience
- Vol. 46 (45)
Abstract
Rapid-acting antidepressants have challenged the long-standing view that therapeutic improvement in major depressive disorder requires chronic treatment with monoaminergic agents. Ketamine and classical psychedelics act through distinct proximal targets, yet both can produce rapid and persistent behavioral effects that implicate synaptic and circuit plasticity as the core mechanisms of antidepressant action. This review, based on a minisymposium presented at the 2026 Society for Neuroscience meeting, examines how brief pharmacological perturbations translate into lasting changes in mood-related networks. We first discuss hippocampal mechanisms underlying ketamine action, which include brain-derived neurotrophic factor (BDNF)/tropomyosin receptor kinase B (TrkB)-dependent homeostatic potentiation, TrkB cross talk with metabotropic glutamate receptor 5 (mGluR5) at CA3?CA1 synapses, extracellular signal-regulated kinase (ERK)-dual-specificity phosphatase 6 (DUSP6)-mediated extension of synaptic metaplasticity, and BDNF release at mossy fiber synapses and dentate gyrus neuronal maturation. We then consider how these local plasticity mechanisms interface with distributed circuits that regulate motivation, stress coping, and reward. Across brain regions, emerging work highlights the importance of cell type- and region-specific mechanisms that mediate ketamine's therapeutic actions. We expand on local prefrontal cortical inhibitory cellular signaling dynamics, including the interplay of various G-protein-coupled receptors (GPCRs) in cortical somatostatin interneurons and input-specific adaptations in accumbal circuits. Finally, we compare ketamine with psilocybin, an emerging therapeutic classic psychedelic for treatment-resistant depression that targets the 5-hydroxytryptamine 2A (5-HT2A) receptor primarily. A recurring theme is that an interplay of GPCRs can help shape the timing, localization, and persistence of ketamine-induced neuroplasticity. Together, these studies suggest that antidepressant efficacy arises not from a single pathway or brain region but from coordinated, temporally staged plasticity across molecules, synapses, cells, and circuits.Funding Information
- HHS | NIH | National Institute of Mental Health (MH130610)
- National Alliance for Research on Schizophrenia and Depression (27102)
- Wellcome Trust (317708/Z/24/Z)
- HHS | NIH | National Center for Advancing Translational Sciences (KL2TR002385)
This publication has 110 references indexed in Scilit:
- Short-Term and Late-Term Effects of Psilocybin on Symptoms in Major DepressionJAMA Network Open, 2026
- Efficacy and Safety of Psilocybin in Treatment-Resistant Major DepressionJAMA Psychiatry, 2026
- Single-Dose Psilocybin Treatment for Major Depressive DisorderJAMA, 2023
- The effect of ketamine on anhedonia: improvements in dimensions of anticipatory, consummatory, and motivation-related reward deficitsPsychopharmacology, 2022
- Association of Combined Naltrexone and Ketamine With Depressive Symptoms in a Case series of Patients With Depression and Alcohol Use DisorderJAMA Psychiatry, 2019
- Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effectsPsychopharmacology, 2011
- S‐ketamine and GABA‐A‐receptor interaction in humans: an exploratory study with I‐123‐iomazenil SPECTHuman Psychopharmacology: Clinical and Experimental, 2008
- Reduced Prefrontal Glutamate/Glutamine and γ-Aminobutyric Acid Levels in Major Depression Determined Using Proton Magnetic Resonance SpectroscopyArchives of General Psychiatry, 2007
- Reduced Cortical γ-Aminobutyric Acid Levels in Depressed Patients Determined by Proton Magnetic Resonance SpectroscopyArchives of General Psychiatry, 1999
- The concept of major depressionEuropean Archives of Psychiatry and Clinical Neuroscience, 1991